Skip to main content
VolitionRx Limited (VNRX)
NYSEAMERICAN: VNRX · Real-Time Price · USD
2.780
+0.056 (2.06%)
At close: Apr 28, 2026, 4:00 PM EDT
2.940
+0.160 (5.76%)
Pre-market: Apr 29, 2026, 4:31 AM EDT

VolitionRx Revenue

In the year 2025, VolitionRx had annual revenue of $1.73M with 40.04% growth. VolitionRx had revenue of $447.03K in the quarter ending December 31, 2025, with 133.25% growth.

Revenue (ttm)
$1.73M
Revenue Growth
+40.04%
P/S Ratio
12.75
Revenue / Employee
$23,032
Employees
75
Market Cap
22.03M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20251.73M493.87K40.04%
Dec 31, 20241.23M458.21K59.10%
Dec 31, 2023775.30K468.91K153.04%
Dec 31, 2022306.39K216.36K240.30%
Dec 31, 202190.04K76.60K570.25%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
TELA Bio 80.28M
IRIDEX 52.68M
Myomo 40.93M
Cytosorbents 37.06M
Lifeward 22.03M
Pulsenmore 12.55M
Picard Medical 4.94M
IceCure Medical 3.38M
Revenue Rankings

VNRX News

More News